• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在经历埃博拉疫情后在西非抗击新冠疫情。

Fighting COVID-19 in the West Africa after experiencing the Ebola epidemic.

作者信息

Gholizadeh Pourya, Sanogo Moussa, Oumarou Amadou, Mohamed Maad Nasser, Cissoko Yacouba, Saliou Sow Mamadou, Pagliano Pasquale, Akouda Patassi, Soufiane Sid'Ahmed, Iknane Akory Ag, Oury Mamadou, Diallo Safiatou, Köse Şükran, Dao Sounkalo, Samadi Kafil Hossein

机构信息

Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran.

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Health Promot Perspect. 2021 Feb 7;11(1):5-11. doi: 10.34172/hpp.2021.02. eCollection 2021.

DOI:10.34172/hpp.2021.02
PMID:33758750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7967127/
Abstract

Coronavirus disease 2019 (COVID-19) dissemination occurred from December 2019 and quickly spread to all countries. Infected patients with COVID-19 have had a wide range of symptoms, ranging from mild to severe illness. The most mortality was observed in patients with underlying disease and over 45 years. World statistics have shown that the COVID-19 outbreak is most expanded in Middle Eastern, West Asian, European, North, and South American countries, and is least expanded in African countries. Therefore, the aim of the paper was the evaluation of six African countries including Mali, Mauritania, Niger, Guinea, Togo, and Djibouti to find why this disease is least expanded in African countries. Study was conducted by Questioner for countries health organizers to define their different aspect exposure and fight with COVID-19 including epidemiology, clinical aspects of the disease, case definitions, diagnosis laboratory confirmation, and referral of cases by the portal of entry, case management, and disease prevention in these countries. According to this opinion review, due to the low international flights and low domestic travel, the spread, and prevalence of COVID-19 was low and the return of the immigrants of these countries has caused the spread of COVID-19 among these countries. Experience, preparation, and impact of previous infections epidemic such as the Ebola virus epidemic would have beneficial, which have promoted certain reflexes among people that cause low dissemination in these countries.

摘要

2019年冠状病毒病(COVID-19)于2019年12月开始传播,并迅速蔓延至所有国家。COVID-19感染患者有广泛的症状,从轻症到重症。观察到有基础疾病的患者和45岁以上患者的死亡率最高。世界统计数据显示,COVID-19疫情在中东、西亚、欧洲、北美和南美国家传播最为广泛,在非洲国家传播最少。因此,本文的目的是评估包括马里、毛里塔尼亚、尼日尔、几内亚、多哥和吉布提在内的六个非洲国家,以找出该疾病在非洲国家传播最少的原因。通过向各国卫生组织者提问进行研究,以确定他们在应对COVID-19方面的不同暴露情况和应对措施,包括流行病学、疾病的临床方面、病例定义、诊断实验室确认、通过入境口岸转诊病例、病例管理以及这些国家的疾病预防。根据这一观点综述,由于国际航班和国内旅行较少,COVID-19的传播和流行程度较低,而这些国家移民的回流导致了COVID-19在这些国家的传播。诸如埃博拉病毒疫情等以往感染性流行病的经验、准备工作和影响可能会产生有益作用,这些经验促使人们产生了某些反应,从而导致该疾病在这些国家传播较少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6996/7967127/ee1ed9300c5f/hpp-11-5-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6996/7967127/1c2beb5d4dc6/hpp-11-5-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6996/7967127/ee1ed9300c5f/hpp-11-5-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6996/7967127/1c2beb5d4dc6/hpp-11-5-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6996/7967127/ee1ed9300c5f/hpp-11-5-g002.jpg

相似文献

1
Fighting COVID-19 in the West Africa after experiencing the Ebola epidemic.在经历埃博拉疫情后在西非抗击新冠疫情。
Health Promot Perspect. 2021 Feb 7;11(1):5-11. doi: 10.34172/hpp.2021.02. eCollection 2021.
2
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.撒哈拉以南非洲的新冠病毒监测系统:关于持续存在和传播以指导政策的建模研究
J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248.
3
Modeling and tracking Covid-19 cases using Big Data analytics on HPCC system platformm.在惠普高性能计算集群(HPCC)系统平台上使用大数据分析对新冠病毒疾病(Covid-19)病例进行建模和追踪。
J Big Data. 2021;8(1):33. doi: 10.1186/s40537-021-00423-z. Epub 2021 Feb 15.
4
The West African ebola virus disease epidemic 2014-2015: A commissioned review.2014 - 2015年西非埃博拉病毒病疫情:委托评审报告
Niger Postgrad Med J. 2016 Apr-Jun;23(2):49-56. doi: 10.4103/1117-1936.186299.
5
Ebola virus disease 2013-2014 outbreak in west Africa: an analysis of the epidemic spread and response.2013 - 2014年西非埃博拉病毒病疫情:疫情传播与应对分析
Int J Microbiol. 2015;2015:769121. doi: 10.1155/2015/769121. Epub 2015 Mar 17.
6
Impact of international travel dynamics on domestic spread of 2019-nCoV in India: origin-based risk assessment in importation of infected travelers.国际旅行动态对 2019 年新型冠状病毒在印度国内传播的影响:基于起源的感染旅行者输入风险评估。
Global Health. 2020 May 12;16(1):45. doi: 10.1186/s12992-020-00575-2.
7
Impact of infectious disease epidemics on tuberculosis diagnostic, management, and prevention services: experiences and lessons from the 2014-2015 Ebola virus disease outbreak in West Africa.传染病流行对结核病诊断、管理及预防服务的影响:西非2014 - 2015年埃博拉病毒病疫情的经验与教训
Int J Infect Dis. 2017 Mar;56:101-104. doi: 10.1016/j.ijid.2016.10.010. Epub 2016 Nov 3.
8
How Is the World Responding to the Novel Coronavirus Disease (COVID-19) Compared with the 2014 West African Ebola Epidemic? The Importance of China as a Player in the Global Economy.与 2014 年西非埃博拉疫情相比,世界对新型冠状病毒病(COVID-19)的反应如何?中国作为全球经济参与者的重要性。
Am J Trop Med Hyg. 2020 May;102(5):924-925. doi: 10.4269/ajtmh.20-0135.
9
Outbreaks-of Ebola virus disease in the West African sub-region.西非次区域的埃博拉病毒病疫情。
Afr J Med Med Sci. 2014 Jun;43(2):87-97.
10
Laboratory Response to 2014 Ebola Virus Outbreak in Mali.实验室对2014年马里埃博拉病毒疫情的应对措施。
J Infect Dis. 2016 Oct 15;214(suppl 3):S164-S168. doi: 10.1093/infdis/jiw200.

引用本文的文献

1
Improving testing capacity for COVID-19: experiences and lessons from Senegal, Uganda, Nigeria, and the Democratic Republic of Congo.提高 COVID-19 检测能力:塞内加尔、乌干达、尼日利亚和刚果民主共和国的经验和教训。
Front Public Health. 2023 Nov 16;11:1202966. doi: 10.3389/fpubh.2023.1202966. eCollection 2023.
2
Genetic diversity of isolates from northwest of Iran during COVID-19 era.新冠疫情期间伊朗西北部分离株的遗传多样性。
Egypt J Med Hum Genet. 2023;24(1):3. doi: 10.1186/s43042-023-00383-4. Epub 2023 Jan 9.
3
Cross-sectional study of COVID-19 knowledge, beliefs and prevention behaviours among adults in Senegal.

本文引用的文献

1
Study presence of COVID-19 (SARS-CoV-2) in the sweat of patients infected with Covid-19.研究 COVID-19(SARS-CoV-2)在感染新冠病毒患者汗液中的存在情况。
Microb Pathog. 2020 Dec;149:104556. doi: 10.1016/j.micpath.2020.104556. Epub 2020 Oct 5.
2
Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19).新型冠状病毒肺炎(COVID-19)患者肝脏生物标志物的改变
J Inflamm Res. 2020 Jul 1;13:285-292. doi: 10.2147/JIR.S257078. eCollection 2020.
3
Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19).
塞内加尔成年人对 COVID-19 的知识、信念和预防行为的横断面研究。
BMJ Open. 2022 May 26;12(5):e057914. doi: 10.1136/bmjopen-2021-057914.
4
National survey on deceased donor organ transplantation during the COVID-19 pandemic in Japan.日本新冠疫情期间 deceased donor 器官移植全国调查。 (注:“deceased donor”直译为“已故捐赠者” )
Surg Today. 2022 May;52(5):763-773. doi: 10.1007/s00595-021-02388-1. Epub 2021 Oct 23.
5
SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review.SARS-CoV-2(Covid-19)疫苗的结构、机制和效力:综述。
Int J Biol Macromol. 2021 Oct 1;188:740-750. doi: 10.1016/j.ijbiomac.2021.08.076. Epub 2021 Aug 14.
6
Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.非洲和中东国家民众对新冠疫苗的态度、接受度及社会信任度。
Health Promot Perspect. 2021 May 19;11(2):171-178. doi: 10.34172/hpp.2021.21. eCollection 2021.
7
COVID-19 reinfection in a healthcare worker after exposure with high dose of virus: A case report.一名医护人员在接触高剂量病毒后发生新冠病毒再次感染:病例报告
Clin Case Rep. 2021 Jun 23;9(6):e04257. doi: 10.1002/ccr3.4257. eCollection 2021 Jun.
SARS-CoV-2(COVID-19)的虚拟筛选与抗病毒治疗联合研究。
Microb Pathog. 2020 Sep;146:104241. doi: 10.1016/j.micpath.2020.104241. Epub 2020 May 5.
4
Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period.新冠病毒(COVID-19)暴发期间的临床表现、诊断、预防与控制
Infez Med. 2020;28(2):153-165.
5
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
6
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
8
Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus.蝙蝠中丰富的与SARS相关冠状病毒基因库的发现为SARS冠状病毒的起源提供了新见解。
PLoS Pathog. 2017 Nov 30;13(11):e1006698. doi: 10.1371/journal.ppat.1006698. eCollection 2017 Nov.
9
Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation.中东呼吸综合征冠状病毒在单峰驼中的流行情况:暴发调查。
Lancet Infect Dis. 2014 Feb;14(2):140-5. doi: 10.1016/S1473-3099(13)70690-X. Epub 2013 Dec 17.
10
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.中东呼吸综合征冠状病毒(MERS-CoV):冠状病毒研究小组声明
J Virol. 2013 Jul;87(14):7790-2. doi: 10.1128/JVI.01244-13. Epub 2013 May 15.